Speakers

Gabriele Arendt, MD.
Gabriele Arendt, MD.

Gabriele Arendt, MD, is associate Professor in Neurology, University Hospital of Duesseldorf, Germany. Since 1987, she chairs the Neuro-AIDS out-patient department of the hospital with about 1100 patients/year. The Duesseldorf HIV cohort comprises by now almost 5000 patients. She acquired her medical and scientific degrees in the University of Duesseldorf, then specialised on psychiatry and later on neurology and neurophysiology. Her scientific interest focuses on motor abnormalities in HIV-positive patients, disturbances of the dopaminergic pathways in these patients and on the significance of cytokines for the neuropathogenesis of HIV-associated dementia.

She is in the editorial boards of the Journal of NeuroVirology, the Journal of NeuroAIDS and of Neurobehavioral HIV Medicine, an open access journal. She is a member of the German Aids Society. She has written more than 150 papers, HIV/AIDS chapters in most of the German standard textbooks and three books. She has designed and conducted many national multicenter studies and participated in international studies.

Fátima Brañas, MD
Fátima Brañas, MD
Medical Specialist in Geriatrics. Doctor in medicine. Associate Professor of Medicine at the Complutense University of Madrid. Head of Geriatrics Service at the Infanta Leonor University Hospital (Madrid). National coordinator of the multicenter study HIV-FUNCFRAIL: Spanish cohort of patients older than 50 years with HIV infection for the study of frailty and physical function. GeSIDA Study 8917. FIS17 / 00859. In the clinical area, she completed his training in HIV with a stay in the HIV Infectious Diseases Service of Mount Sinai Hospital in New York in 2015 and currently has launched a specific circuit for the care of the elderly patient with HIV infection in the Infanta Leonor University Hospital in collaboration with infectious diseases specialists with a multidisciplinary approach.
Andrea Calcagno, MD, DTM&H.
Andrea Calcagno, MD, DTM&H.

He is temporary Assistant Professor at the University of Torino (Department of Medical Sciences, Infectious Diseases). Infectious Diseases Specialist (University of Torino, Italy); Diploma in Tropical Medicine and Hygiene (Mahidol University, Bangkok, Thailand). He is member of the Panel of the Italian Guidelines on the Use of Antiretrovirals and Management of patients living with HIV.

He has experience as a Clinicians in Infectious Diseases and Tropical Medicine (Sudan, Thailand, Burundi); several phase II, III and IV studies in antiretroviral treatment trials.

His main field of interest is the clinical pharmacology and pharmacogenetics of anti-infective agents (antiretroviral, antibiotic, antifungals) and the central nervous system complication of HIV-infection.

Paola Cinque, MD, Ph. D.
Paola Cinque, MD, Ph. D.

She is currently working as senior physician at the Department of Infectious Diseases and responsible of the Neurovirology Research Unit at the Research Division of Immunology, Transplantation and Infectious Diseases of San Raffaele Scientific Institute, Milan, Italy, and as contract Professor of Infectious Diseases at San Raffaele University.

Her research group is mainly involved in studies on HIV Infection of the Central Nervous System, Progressive Multifocal Leukoencephalopathy and other HIV-associated CNS complications.

She is a panel member of the Italian HIV Treatment Guidelines, of the EACS Co-morbidities and of the Opportunistic Infections Guidelines, and of the NIH/CDC/IDSA Guidelines for the Prevention and Treatment of Opportunistic Infections.in HIV-Infected Adults and Adolescents.

Guida da Ponte, Ph. D.
Guida da Ponte, Ph. D.

Guida da Ponte is a Psychiatry Consultant, Coordinator of Liaison Psychiatry Unit, in Centro Hospitalar Barreiro-Montijo, located in the suburban area of Lisbon, Portugal. One of the major fields of practice is with HIV patients with a psychiatric outpatient clinic dedicated to this condition. Author of scientific publications, mainly in the areas of neurocognitive disorders, depression, anxiety and psychopharmacology and antiretroviral interactions. Other major area of interest is Psycho-Oncology, as PhD student of Medical School of Lisbon, University of Lisbon.

Helen Dolengevich Segal
Helen Dolengevich Segal
Psychiatrist responsible for the Dual Pathology Program of the Henares University Hospital. From 2017 to 2019 psychiatrist of the program "Sex, Drugs and You" of the NGO Apoyo Positivo, aimed at people with problems related to the practice of Chemsex. Degree in Medicine and Surgery from La Salle University in Mexico D.F. with Honorific Mention. Specialist in Psychiatry via MIR at Hospital Ramón y Cajal in Madrid. Degrees of Specialist in Severe Dual Pathology from CEU University, Specialist in Psychiatric Emergencies and ADHD throughout Life by Fundación Psiforificación-Universidad de Alcalá. The Doctoral Thesis in progress at the Francisco de Vitoria University, in relation to Chemsex. Member of the Spanish Society of Dual Pathology, the Spanish Society of Psychiatry, World Association of Dual Disorders, ASEXSAME and Socidrogalcohol. Clinical Associate Professor of Psychiatry at the Francisco de Vitoria University. Edition and coordination of the book New Psychoactive Drugs (Entheos, 2015). Publication of various national and international scientific articles, as well as book chapters, lectures and communications in specialized congresses at the national and international level, mainly on the subject of New Psychoactive Drugs and Chemsex.
Mina Kakaiya
Mina Kakaiya
Mina is a social entrepreneur, speaker, author, wellbeing coach, mental health and mindfulness trainer. She has been a volunteer peer mentor with Positively UK over the last 7 years and has supported the development of the national BHVIA HIV standards for Peer Support. A speaker at the BHIVA 2019 and speaker on emotional resilience at the Gilead international HIV and Your Body: Going the full 360 event in Amsterdam September 2019. Involved in Gilead campaign to support women living with HIV to feel positive about living a long and healthy life. In April 2020 post Covid 19 she delivered emotional resilience base sessions with Positively UK. Mina has a background in health and social care and working in collaboration across and not for profit sector and education in developing a diverse range of mental health and wellbeing projects and initiatives. Influencing NHS service commissioning to improving health and social inequalities for the wider population and those experiencing mental health problems and long term conditions. Mina is a MHFA (Mental Health First Aid) trainer and developed peer support training in Mental Health, HIV and Domestic Violence. Mina holds a degree in Neuroscience and a Masters in CSR (Corporate Social Responsibility). She is passionate about promoting inner wellbeing towards personal transformation of individuals and communities. For more information please connect with Mina on LinkedIn.
Scott Letendre, MD.
Scott Letendre, MD.

Scott Letendre, M.D., is Professor of Medicine in Residence in the Division of Infectious Diseases at the University of California, San Diego (UCSD). He graduated from Georgetown University School of Medicine and, following his residency in internal medicine at the Naval Medical Center in San Diego, he completed fellowships in Infectious Disease Medicine at Duke University and in Neurologic HIV Research at UCSD. At UCSD, Dr. Letendre performs translational, patient-oriented research of the central nervous system complications of chronic infections, including HIV, HCV, and CMV. As part of a multidisciplinary research team, he conducts treatment trials of neurocognitively impaired individuals and analyzes their response to therapy as well as studies of the pharmacokinetics of antiretrovirals, the effect of comorbidities, and biomarker correlates of disease. Dr. Letendre is also an investigator in the UCSD unit of the AIDS Clinical Trials Group.

He participates in several international research projects, including projects based in China, India, Zambia, and Romania. Dr. Letendre balances his research activities with regular, clinical outpatient and inpatient care of people living with HIV and other infectious diseases. Dr. Letendre also teaches in the Microbiology course at the UCSD School of Medicine and chairs the UCSD Institutional Biosafety Committee. Dr. Letendre has published in several peer-reviewed journals including AIDS, Clinical Infectious Diseases, Journal of Infectious Diseases, Neurology, Journal of Virology, Journal of Neurovirology, Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy, and Journal of Neuroimmunology.

Jose A. Muñoz-Moreno, Ph. D.
Jose A. Muñoz-Moreno, Ph. D.

Jose A. Muñoz-Moreno is a clinician and researcher at the Lluita contra la SIDA Foundation, located in the Germans Trias i Pujol University Hospital, in Barcelona (Catalonia, Spain). He earned the Ph.D. degree in Neurosciences in 2012 (Cum Laude), and currently he is also a collaborating professor with the Universitat de Barcelona (UB) and the Universitat Autònoma de Barcelona (UAB).

Muñoz-Moreno is involved in projects that address psychology and the human behaviour associated with HIV infection. In terms of study, he mostly investigates the neurocognitive features of HIV infection, the impact of HIV and antiretroviral treatments on quality of life and emotional status, and adherence to antiretroviral therapy.

Muñoz-Moreno’s recent work particularly focuses on assessment methods to detect HIV-related neurocognitive changes and the current profile of neurocognitive impairment in people living with HIV infection.

Ignacio Pérez-Valero, MD, Ph. D.
Ignacio Pérez-Valero, MD, Ph. D.
Ignacio Pérez-Valero MD PhD is a 41 years-old Consultant Physician of Internal Medicine at the La Paz University Hospital and a Senior Clinical Researcher at the IDIPAZ Research Institute (Madrid, Spain).
Annemiek Shadé, MD, PhD
Annemiek Shadé, MD, PhD
Annemiek Schadé works as a psychiatrist since 1994 and since 2005 at the HIV Expert and Treatment Center on HIV and Mental Health and as a consultant at the University Hospital VU Medical Center in Amsterdam. She is a trainer and tutor for medical residents and interns psychiatry. The past years, she provided trainings and E-learning on HIV and Mental Health. She published a study book (in Dutch) and (research) articles on HIV and Mental Health, in English and Dutch
Milton Wainberg, MD
Milton Wainberg, MD
Milton Wainberg is Professor of Clinical Psychiatry and Director of Global Mental Health Research in the Department of Psychiatry, Columbia University. He is Director of the NIMH-funded Columbia University Global Mental Health Implementation Science T32-Post Doctoral Fellowship, NIMH/Fogarty International-funded Portuguese-speaking African countries Mental Health Implementation Research Training Program, Founding Chair of the Caucus of Global Mental Health and Psychiatry of the American Psychiatric Association, and Medical Director of the Columbia University HIV Mental Health Training Project. Dr. Wainberg is the Chair of the Mental Health HIV Clinical Guidelines Committee of the New York State Department of Health/AIDS Institute, and has been Principal investigator or investigator of multiple NIMH, NIAAA, NIDA and CDC studies addressing the intersection of mental illness, substance use and abuse, HIV-associated fatigue, sexual compulsivity and HIV prevention and adherence to care, as well as the stigma and discrimination associated with mental illness, HIV, race/ethnicity and being a sexual minority. Dr. Wainberg is the Principal Investigators of the NIMH-funded PRIDE sSA - Partnerships in Research to Implement and Disseminate Sustainable and Scalable Evidence-based Practices: sub-Saharan Africa which comprises a large scale up study delivering comprehensive efficacious and sustainable psychiatric care in three Provinces of Mozambique, and capacity building of a collaborative research network that will train service providers, investigators and policy-makers from Botswana, Malawi, Mozambique, South Africa, Zambia.  His research to practice work aims to decrease the global mental health treatment and research gaps.
Alan Winston, MD.
Alan Winston, MD.
Dr.Winston is a Clinical Senior Lecturer in Communicable Diseases at Imperial College, London and Consultant Physician in HIV and GU Medicine at St. Mary’s Hospital, London. Dr.Winston is a clinical researcher with an MD in clinical pharmacology and runs a portfolio of clinical trials assessing non-infectious co-morbidities, including cerebral function, in relation to HIV disease with a focus on antiretroviral pharmacokinetics and pharmacodynamics in sanctuary sites.

View Programme